Population Diagnostics, Inc. Company Profile

01:02 EDT 27th October 2016 | BioPortfolio

Population Diagnostics, Inc. (PDx, is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medicine tests. PDx’s technology, which reveals the genetic causes of complex diseases such as autism, diabetes, Parkinson’s, and Alzheimer’s, enables development of early detection diagnostic tests that predict pre-symptomatically why some individuals will suffer from debilitating diseases while others will not. When applied to drug discovery, the technology enables pharmaceutical companies to develop targeted therapies and companion diagnostics. Its novel technology and exclusive products places PDx in a prime position to (i) transform how physicians diagnose and manage disease in their patients and (ii) enable pharmaceutical companies to expand the number of available therapies and market drugs with higher efficacy and safety.

News Articles [914 Associated News Articles listed on BioPortfolio]

In Vitro Diagnostics Market to Witness Swift Growth

The global in vitro diagnostics (IVD) market is expected to expand rapidly owing to an aging population, chronic lifestyle related...

Why The World Needs An Essential Diagnostics List

Without diagnostics, medicine is blind. And yet, diagnostics receive much less attention than vaccines and drugs.

BRIEF-Zimmer Biomet acquires CD Diagnostics

* Announces Acquisition of CD Diagnostics, a fully-integrated, Delaware-based diagnostics company

Sekisui Diagnostics expands point of care diagnostics offering with FastPack IP system

Sekisui Diagnostics has significantly expanded its point of care (POC) diagnostics product line through a recent partnership agreement with Qualigen.

New population data provide insight on aging, migration

(International Institute for Applied Systems Analysis) A new dataset provides a comprehensive look at population dynamics in Europe, including the influence of migration on population growth and the e...

Zimmer Biomet Acquires CD Diagnostics Strengthening its Musculoskeletal Diagnostics Offering

WARSAW, Ind., Aug. 15, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the acquisition of CD Diagnostics, a f...

Cerner Emphasizes Population Health but Pay Attention to the Details

Support for population health is a major strategic goal in the EHR world but what exactly does the term mean? The topic commands considerable mindshare for Cerner which has created a special landing p...

UPDATE 2-Danaher to buy Cepheid in $4 bln deal to expand in diagnostics

Sept 6 (Reuters) - Danaher Corp said on Tuesday it would buy molecular diagnostics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diagnostics business.

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]


Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [1918 Associated PubMed Articles listed on BioPortfolio]

Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.

The importance of RAS mutation in carcinogenesis is established, and knowledge of an individual cancer's mutation status is important for optimal treatment.

Genomic epidemiology of gonococcal resistance to extended spectrum cephalosporins, macrolides, and fluoroquinolones in the US, 2000-2013.

 Treatment of Neisseria gonorrhoeae infection is empiric and based on population-wide susceptibilities. Increasing antimicrobial resistance underscores the potential importance of rapid diagnostics,...

Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders.

The growing number of identified genetic disease risk variants across dog breeds challenges the current state-of-the-art of population screening, veterinary molecular diagnostics, and genetic counseli...

Characteristics of lymphoproliferative disorders with more than one aberrant cell population as detected by 10-color flow cytometry.

We have evaluated the frequency of lymphoproliferative disorders with more than one aberrant population of monotypic B-cells detected during routine hematopathological diagnostics.

Next-Generation Sequencing in Cancer Diagnostics.

This commentary highlights the article by Misyura et al that underscores the use of next-generation sequencing platforms for detection and verification of somatic variants.

Clinical Trials [1208 Associated Clinical Trials listed on BioPortfolio]

BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes

Pacemaker technology is constantly evolving. In the past 10 years, numerous advancements have been made in pacemaker therapy, diagnostics and connectivity. These advancements include autom...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer

Quality of Life-Diagnostics and -Therapy in Individual Patients with Breast Cancer. A randomized study including 200 patients, 5 clinics and 43 general practitioners as coordinating docto...

Implementation of Quality of Life Diagnostics and Therapy

Implementation and Evaluation of Implementation of Quality of Life Diagnostics and Therapy in Individual Patients with Breast Cancer. A prospective study including 170 patients, 5 clinics ...

Companies [1165 Associated Companies listed on BioPortfolio]

Population Genetics Technologies Ltd

Population Genetics Technologies Ltd was founded in 2005 by Nobel Laureate Dr Sydney Brenner; by Dr Sam Eletr, a founder of Applied Biosystems and of Lynx Therapeutics; and by Dr ...

Veterinary Diagnostics Institute (VDxI), Inc.

VDxI, a California corporation, is a veterinary clinical ventures company dedicated to the introduction of innovative biomarkers for companion animals. Through collaboration with ...

Population Diagnostics, Inc.

Population Diagnostics, Inc. (PDx, is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medici...

The Population Health Alliance

The Population Health Alliance (PHA) is a global trade association of the population health industry. Its more than 80 members represent stakeholders from across the health care d...

Quintiles and Population Genetics Technologies Ltd.

Co-founded by Nobel Laureate Dr. Sydney Brenner, Population Genetics Technologies creates products that accelerate large-scale population studies, through the simultaneous analysi...

More Information about "Population Diagnostics, Inc." on BioPortfolio

We have published hundreds of Population Diagnostics, Inc. news stories on BioPortfolio along with dozens of Population Diagnostics, Inc. Clinical Trials and PubMed Articles about Population Diagnostics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Population Diagnostics, Inc. Companies in our database. You can also find out about relevant Population Diagnostics, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Autism affects half a million people in the UK. Men are affected more than women. People with autism have said that the world, to them, is a mass of people, places and events which they struggle to make sense of, and which can cause them considerable a...

Corporate Database Quicklinks

Searches Linking to this Company Record